Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hair loss affects self-esteem and quality of life; treatments can help.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.